首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Calreticulin and Arginylated Calreticulin Have Different Susceptibilities to Proteasomal Degradation
【2h】

Calreticulin and Arginylated Calreticulin Have Different Susceptibilities to Proteasomal Degradation

机译:钙网蛋白和精氨化钙网蛋白对蛋白酶体降解的敏感性不同

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Post-translational arginylation has been suggested to target proteins for proteasomal degradation. The degradation mechanism for arginylated calreticulin (R-CRT) localized in the cytoplasm is unknown. To evaluate the effect of arginylation on CRT stability, we examined the metabolic fates and degradation mechanisms of cytoplasmic CRT and R-CRT in NIH 3T3 and CHO cells. Both CRT isoforms were found to be proteasomal substrates, but the half-life of R-CRT (2 h) was longer than that of cytoplasmic CRT (0.7 h). Arginylation was not required for proteasomal degradation of CRT, although R-CRT displays ubiquitin modification. A CRT mutant incapable of dimerization showed reduced metabolic stability of R-CRT, indicating that R-CRT dimerization may protect it from proteasomal degradation. Our findings, taken together, demonstrate a novel function of arginylation: increasing the half-life of CRT in cytoplasm.
机译:已建议翻译后的精氨酰化靶向蛋白质以用于蛋白酶体降解。位于细胞质中的精氨化钙网蛋白(R-CRT)的降解机理尚不清楚。为了评估精氨酰化对CRT稳定性的影响,我们检查了NIH 3T3和CHO细胞中细胞质CRT和R-CRT的代谢命运和降解机制。发现这两种CRT亚型都是蛋白酶体底物,但R-CRT的半衰期(2小时)比细胞质CRT的半衰期(0.7小时)更长。尽管R-CRT显示泛素修饰,但蛋白酶体降解CRT不需要精氨酰化。无法二聚化的CRT突变体显示R-CRT的代谢稳定性降低,表明R-CRT二聚化可保护其免受蛋白酶体降解。我们的发现加在一起,证明了精氨酰化的新功能:增加CRT在细胞质中的半衰期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号